Fordyce Marshall's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Jan 10, 2025
- Accession no.
- 0001415889-25-001242
- Filed
- Jan 10, 2025
- Trade date
- Jan 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $730.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fordyce MarshallCIK 0001859453 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Class A Common Stock | MOption exerciseAcquired | +9,975 | $2.90 | +$28,927.5 | 153,578 | Direct | |
| Jan 8, 2025 | Class A Common Stock | SSaleDisposed | −9,975 | $41.53 | −$414,261.75 | 143,603 | Direct | |
| Jan 8, 2025 | Class A Common Stock | MOption exerciseAcquired | +5,650 | $2.90 | +$16,385 | 149,253 | Direct | |
| Jan 8, 2025 | Class A Common Stock | SSaleDisposed | −5,650 | $42.03 | −$237,469.5 | 143,603 | Direct | |
| Jan 8, 2025 | Class A Common Stock | MOption exerciseAcquired | +1,875 | $2.90 | +$5,437.5 | 145,478 | Direct | |
| Jan 8, 2025 | Class A Common Stock | SSaleDisposed | −1,875 | $42.00 | −$78,750 | 143,603 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Class A Common Stock | MOption exerciseDisposed | −15,625 | $0.00 | $0 | 610,926 | Direct | |
| Jan 8, 2025 | Class A Common Stock | MOption exerciseDisposed | −1,875 | $0.00 | $0 | 609,051 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.